Armstrong, A., Campanati, A., Iversen, L., Praestegaard, M., & Estebaranz, J. L. L. (2023). Treatment or Psoriasis with Calcipotriene and Betamethasone Dipropionate (CAL/BDP) Cream Showed Significantly Higher Proportion of Patients with an Absolute mPASI≤2 Compared to CAL/BDP Gel/Topical Suspension in a Post-Hoc Aanalysis of Two Phase 3 Studies. SKIN The Journal of Cutaneous Medicine, 7(6), s233. https://doi.org/10.25251/skin.7.supp.233